Table 1.
Feature | All patients, nā=ā1055 |
---|---|
Age (years), mean (SD) | 52.8 (14.2) |
Female, % | 76.1 |
Time between the onset of symptoms and the baseline visit (months), mean (SD) | 28.7 (40.4) |
Diabetes mellitus, % | 10.6 |
Arterial hypertension, % | 27.3 |
Dyslipidemia, % | 17.5 |
Smoking, % | 39 |
Family psoriasis, % | 6.7 |
Cutaneous psoriasis, % | 7.8 |
Patient global VAS (0-100), mean (SD) | 50.7 (20.6) |
Tender joints (28), mean (SD) | 3.4 (3.5) |
Swollen joints (28), mean (SD) | 0.7 (1.6) |
ESR, mean (SD) | 20.1 (17.2) |
CRP, mean (SD) | 4.7 (13) |
DAS28-ESR, mean (SD) | 3.3 (1.1) |
CDAI, mean (SD) | 12.9 (7.2) |
HAQ, mean (SD) | 0.7 (2.5) |
Rheumatoid factor, % | 21.2 |
ACPAs, % | 9.4 |
X-ray bone erosions, % | 10.3 |
Ultrasound synovitis with positive power Doppler signal, % (hand and wrist) | 7.7 |
SD, standard deviation; VAS, visual analog scale; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; DAS28-ERS, Disease Activity Index in 28 joints-erythrocyte sedimentation rate; CDAI, Clinical Disease Activity Index; HAQ-DI, Health Assessment Questionnaire-Disability Index; ACPAs, anticitrullinated protein antibodies.